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Conclusion: STEMI patients with a CTO in a non IRA have an increased mortality,
regardless of the coronary location.
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Background: The aim of this study is to compare the safety and efficacy of Sirolimus
(SES), Paclitaxel (PES), Zotarolimus (ZES-R/ Endeavor Resolute), BiolimusA9 (BES),
EPC capture (ECS) and Everolimus-eluting stent (EES) on the outcome of patients
with chronic total occlusion (CTO).
Methods: A prospective analysis of 1576 patients with 1738 CTOs (396 SES, 526
PES, 219 ZES-R, 209 BES, 148 ECS, 240 EES) in six high volume Asian centers after
successful recanalization of CTO was performed. The study endpoints were 30 days
and 12 months major adverse cardiac events (MACE), 12 months angiographic
restenosis and target lesion revascularization (TLR).
Results: See table for clinical results.
Conclusion: The use of drug-eluting stents in patients with CTO was safe with low
acute complication. Patients treated with 2nd generation DES such as ZES-R, BES
and EES showed lesser rate of restenosis compared with 1st generation drug-eluting
stents.
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Background: There is a paucity of data on long-term clinical outcomes of patients
with insulin dependent diabetes mellitus (IDDM) compared with non-IDDM
undergoing percutaneous coronary intervention (PCI) for chronic total occlusions
(CTO).
Methods: Between 1998 and 2007, a total of 1791 pts with 1852 CTO underwent PCI
at three centers in the US, Italy and South Korea. Time-to-event analyses were
performed using Kaplan-Meier statistics and the log-rank statistic was used to test for
differences between pts with and without DM. Cox regression was used for multivariate
analysis.
Results: A total of 395 (23%) patients had DM, 164 had IDDM (42%) and 231 had
non-IDDM (58%). Procedural success was similar in pts with IDDM and non-IDDM
(68% vs. 71%, p=0.48). After a successful procedure, stents were implanted in 106
patients with IDDM (87% DES) and 159 patients with Non-IDDM (69% DES).Median
follow-up duration was 1080 days. Five-year mortality was significantly increased in
patients with IDDM (23% vs. 7%, p=0.02, figure 1a). After multivariate adjustment,
IDDM remained an independent predictor of mortality (HR 2.25, 95% CI 1.04-4.87,
p=0.04). Other independent predictors were age (HR 1.1, p<0.01) and procedural
success (HR 0.44, p=0.03). Five-year TVR rates after successful PCI were similar in
patients with IDDM and Non-IDDM (24% vs. 27%, p=0.56, figure 1b).
Conclusion: In diabetic patients undergoing CTO PCI, IDDM was an independent
predictor of 5-year mortality. After a successful procedure, TVR rates were similar in
patients with IDDM and non-IDDM.
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Background: Since traditional coronary angiography provides images of the coronary
vessel lumen, chronic total occlusions (CTO) segments are not visible using this
modality. Multislice Computed Tomography (MSCT) provides information on the soft
tissue surrounding the vessel lumen, so it can be used to identify morphological features
such as actual length of the occluded segment, tortuosity and the amount of
calcification. The 3D nature of MSCT allows accurate measurements of length that do
not suffer from calibration limitations and foreshortening. The purpose of this study
was to evaluate the feasibility and operator-perceived added value of advanced software
that provides real time fusion of MSCT images onto the live fluoroscopy during CTO
recanalization.
Methods: In this feasibility study, a software prototype (GE Healthcare, Waukesha,
US) allowing MSCT image fusion with fluoroscopy was used. Manual registration was
performed using anatomical landmarks, such as the vessel ostia and calcifications. This
initial phase of image fusion enabled the operator to plan the procedure. Visualized
portions of the occluded vessel were displayed over the fluoroscopy image in real time,
using ECG gating to match the cardiac phase of the two modalities. The 3D soft tissue
reconstruction of the occluded lumen was displayed on a separate screen allowing real-
time comparison, side by side, between fluoroscopy and MSCT co-registration.
Results: MSCT guided co-registration was performed for a total of 21 CTO
procedures. Real-time registration was successful in all cases and aided in selection of
the view that would provide the least foreshortening and minimal vessel overlapping.
Successful CTO recanalization was achieved in 16 (76%) of the cases. Post-procedural
assessment by the operators ranked the device usefulness as “Very High” in 5 of the
cases, “High” in 9, “Moderate” in 4 and of “Little or No Value” in 3.
Conclusion: This pilot feasibility study demonstrated that MSCT co-registration is
feasible, easily integrated into the standard procedure and is perceived in the majority
of cases as a highly useful tool for CTO recanalization. Further research is warranted
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